T 1180/18 (Therapeutic human albumin solutions / GRIFOLS, S.A.) of 26.10.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T118018.20201026
- Date of decision
- 26 October 2020
- Case number
- T 1180/18
- Petition for review of
- -
- Application number
- 05380116.3
- IPC class
- A61K 51/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Therapeutic human albumin solutions with low prekallicrein activator (PKA) activity and process for obtaining them
- Applicant name
- Grifols, S.A.
- Opponent name
- CSL Behring GmbH
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 123(3) (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention R 103(1)(a) (2007)Rules of procedure of the Boards of Appeal Art 12(4) (2007)Rules of procedure of the Boards of Appeal Art 13(1) (2020)Rules of procedure of the Boards of Appeal Art 25(2) (2020)
- Keywords
- Reimbursement of appeal fee - substantial procedural violation (no)
Late-filed evidence - admittance of documents filed in appeal proceedings
(Late-filed) Requests - admittance in appeal proceedings
Amendments - main request, auxiliary requests 1-21
Amendments - extension beyond the content of the application as filed (yes)
Amendments - auxiliary requests 22-31
Amendments - extension of protection (yes)
Sufficiency of disclosure - auxiliary request 32 (yes)
Novelty - auxiliary request 32 (yes)
Inventive step - auxiliary request 32 (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeals are dismissed.
2. The request for reimbursement of the appeal fee is refused.